Overview

Oxytocin in MRI-HIFU

Status:
Unknown status

Trial end date:
2021-01-01

Target enrollment:

Participant gender:

Summary

Capability of oxytocin in improving the efficacy of MRI-HIFU is studied. Patients undergoing MRI-HIFU treatment are given oxytocin during treatment and the efficacy of the treatment will be analysed by patient reported symptom questionnaires and imaging data.

Phase:

Phase 4

Details

Lead Sponsor:

Turku University Hospital

Treatments:

Oxytocin